Profile
| Metric | Value |
|---|---|
| Full Name | Ambev S.A. |
| Ticker | NYSE: ABEV |
| Exchange | NYSE |
| Sector | Consumer Defensive |
| Industry | Brewers |
| Country | Brazil |
| IPO | |
| Indexes | Not included |
| Website | ambev.com.br |
| Employees | 43,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $2.50 | |
| Price, 1D Change | -0.41% | |
| Market Cap | $39B | |
| TTM Dividend Yield | 7.19% | |
| PE Ratio | 13.95 | |
| Beta | 0.35 | |
| Revenue | $17B | |
| Revenue, 1Y Change | +3.94% | |
| EPS | $0.17 | |
| EPS, 1Y Change | -7.64% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.13 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.17 | |
| EPS Estimate | $0.18 | |
| EPS Est. Change | +6.38% | |
| Revenue | $16.59B | |
| Revenue Estimate | $89.36B | |
| Revenue Est. Change | +438.56% | |
| Current Price | $2.50 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.18 | $0.18 | +1.83% | |
| $0.16 | $0.17 | +4.76% | |
| $0.18 | N/A | +6.38% | |
| $0.19 | N/A | +12.99% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.46B | $15.96B | -2.99% | |
| $87.43B | $16.59B | -81.02% | |
| $89.36B | N/A | +438.56% | |
| $93.79B | N/A | +465.22% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +35.85% | |
| Price, 3Y | -7.76% | |
| Market Cap, 1Y | +34.68% | |
| Market Cap, 3Y | -8.63% | |
| Revenue, 1Y | +3.94% | |
| Revenue, 3Y | +22.90% | |
| EPS, 1Y | -7.64% | |
| EPS, 3Y | +14.31% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $2.50 | |
| SMA 200 | $2.37 | |
| SMA 200 vs Price | -5.27% | |
| SMA 50 | $2.46 | |
| SMA 50 vs Price | -1.56% | |
| Beta | 0.35 | |
| ATR | $0.06 | |
| 14-Day RSI | 54.32 | |
| 10-Day Volatility | 21.75% | |
| 1-Year Volatility | 27.84% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.13 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 4.34% | |
| Total Dividend | $0.11 | |
| Dividends Paid | $752.44M | |
| Payout Ratio | 27.32% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $16.59B | |
| EPS | $0.17 | |
| Gross Profit | $7.92B | |
| Gross Margin | 47.74% | |
| Operating Profit | $3.63B | |
| Operating Margin | 21.89% | |
| Net Income | $2.75B | |
| Net Margin | 16.60% | |
| EBITDA | $4.95B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.04 | |
| Current Ratio | 1.10 | |
| Quick Ratio | 0.86 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 3.42 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 13.95 | |
| PS Ratio | 2.46 | |
| PB Ratio | 2.26 | |
| EV/EBITDA | 7.31 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $15.97B | |
| Cash & Equivalents | $4.83B | |
| Total Assets | $26.86B | |
| Current Assets | $8.77B | |
| Total Liabilities | $10.74B | |
| Current Liabilities | $7.99B | |
| Total Debt | $558.89M | |
| Short Term Debt | $206.61M | |
| Accounts Payable | $3.89B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $13.92B | |
| Operating Expenses | $4.29B | |
| Cost Of Goods Sold | $8.67B | |
| SG&A | $0.00 | |
| D&A | $1.32B | |
| Interest Expense | $0.00 | |
| Income Tax | $860.77M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $4.84B | |
| CFI | -$1.33B | |
| CFF | -$1.60B | |
| Capex | $882.16M | |
| Free Cash Flow | $3.96B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Bernstein | → | |
| UBS | → | |
| HSBC | → | |
| UBS | → | |
| Barclays | → | |
| UBS | → | |
| Morgan Stanley | → | |
| UBS | → | |
| Citigroup | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with ABEV
Data Sources & References
- ABEV Official Website www.ambev.com.br
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1565025/000129281425000831/0001292814-25-000831-index.htm
- ABEV Profile on Yahoo Finance finance.yahoo.com/quote/ABEV
- ABEV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abev
FAQ
What is the ticker symbol for Ambev S.A.?
The ticker symbol for Ambev S.A. is NYSE:ABEV
Does Ambev S.A. pay dividends?
Yes, Ambev S.A. pays dividends. The last payment was $0.13, with an ex-dividend date on December 22, 2025
What sector is Ambev S.A. in?
Ambev S.A. is in the Consumer Defensive sector
What industry is Ambev S.A. in?
Ambev S.A. is in the Brewers industry
What country is Ambev S.A. based in?
Ambev S.A. is headquartered in Brazil
When did Ambev S.A. go public?
Ambev S.A. initial public offering (IPO) was on March 5, 1997
Is Ambev S.A. in the S&P 500?
No, Ambev S.A. is not included in the S&P 500 index
Is Ambev S.A. in the NASDAQ 100?
No, Ambev S.A. is not included in the NASDAQ 100 index
Is Ambev S.A. in the Dow Jones?
No, Ambev S.A. is not included in the Dow Jones index
When was Ambev S.A. last earnings report?
Ambev S.A.'s most recent earnings report was on October 30, 2025
When does Ambev S.A. report earnings?
The next expected earnings date for Ambev S.A. is February 12, 2026